JP2024527345A5 - - Google Patents
Info
- Publication number
- JP2024527345A5 JP2024527345A5 JP2024500069A JP2024500069A JP2024527345A5 JP 2024527345 A5 JP2024527345 A5 JP 2024527345A5 JP 2024500069 A JP2024500069 A JP 2024500069A JP 2024500069 A JP2024500069 A JP 2024500069A JP 2024527345 A5 JP2024527345 A5 JP 2024527345A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- cells
- acid construct
- recombinant
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220139P | 2021-07-09 | 2021-07-09 | |
| US63/220,139 | 2021-07-09 | ||
| PCT/US2022/073563 WO2023283641A1 (en) | 2021-07-09 | 2022-07-08 | Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527345A JP2024527345A (ja) | 2024-07-24 |
| JP2024527345A5 true JP2024527345A5 (https=) | 2025-07-15 |
Family
ID=84802113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500069A Pending JP2024527345A (ja) | 2021-07-09 | 2022-07-08 | 改変東部ウマ脳炎ウイルス、自己複製ｒｎａ構築物、及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240327865A1 (https=) |
| EP (1) | EP4367253A4 (https=) |
| JP (1) | JP2024527345A (https=) |
| KR (1) | KR20240032932A (https=) |
| CN (1) | CN117897494A (https=) |
| AU (1) | AU2022308056A1 (https=) |
| CA (1) | CA3225064A1 (https=) |
| IL (1) | IL309889A (https=) |
| WO (1) | WO2023283641A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113966221B (zh) * | 2019-03-08 | 2026-03-31 | 麻省理工学院 | 合成溶瘤lnp复制子rna和用于癌症免疫治疗的用途 |
| AU2024279218A1 (en) * | 2023-05-26 | 2026-01-15 | Replicate Bioscience, Inc. | Compositions and methods for expression of il-1ra and il-18bp |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102718353B1 (ko) * | 2016-10-17 | 2024-10-15 | 얀센 파마슈티칼즈, 인코포레이티드 | 재조합 바이러스 레플리콘 시스템 및 그의 용도 |
| WO2020076775A1 (en) * | 2018-10-08 | 2020-04-16 | Janssen Pharmaceuticals, Inc. | Alphavirus-based replicons for administration of biotherapeutics |
-
2022
- 2022-07-08 CA CA3225064A patent/CA3225064A1/en active Pending
- 2022-07-08 AU AU2022308056A patent/AU2022308056A1/en active Pending
- 2022-07-08 US US18/577,545 patent/US20240327865A1/en active Pending
- 2022-07-08 EP EP22838604.1A patent/EP4367253A4/en active Pending
- 2022-07-08 IL IL309889A patent/IL309889A/en unknown
- 2022-07-08 JP JP2024500069A patent/JP2024527345A/ja active Pending
- 2022-07-08 WO PCT/US2022/073563 patent/WO2023283641A1/en not_active Ceased
- 2022-07-08 CN CN202280059307.1A patent/CN117897494A/zh active Pending
- 2022-07-08 KR KR1020247004164A patent/KR20240032932A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527345A5 (https=) | ||
| JPWO2017209053A1 (ja) | 新規な遺伝子組換えワクシニアウイルス | |
| RU2017121593A (ru) | Векторы aav, нацеленные на центральную нервную систему | |
| US20200149067A1 (en) | Recombinant herpes simplex virus, preparation method therefor, and application thereof | |
| JPH0655136B2 (ja) | ヒトエリスロポエチンをコードするｄｎａにより形質転換されている細胞 | |
| JP2018533970A (ja) | 改変型インターロイキン１２および腫瘍の治療のための医薬品の製造におけるその使用 | |
| JP2021516957A5 (https=) | ||
| CN109929014B (zh) | 一种抑制鸡先天性免疫反应鸡马立克氏病病毒蛋白及其应用 | |
| WO2024234567A1 (zh) | 一种广谱抗牛科病毒性腹泻病毒的mRNA疫苗及其应用 | |
| CN116802282A (zh) | 经修饰的基孔肯雅病毒和辛德毕斯病毒及其用途 | |
| US20240417751A1 (en) | Rna replicon for improving gene expression and use thereof | |
| KR20040108804A (ko) | 우두 ａｔｉ 프로모터를 사용하는 것에 의한 변형백시니아 바이러스 안카라에서 유전자의 발현 | |
| US8183220B2 (en) | Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same | |
| JP2024535729A5 (https=) | ||
| JP2025514774A5 (https=) | ||
| KR20230123774A (ko) | 코로나바이러스 유래 신규 융합 단백질 및 이의 용도 | |
| US20250325706A1 (en) | Linker peptide, fviii protein or variant thereof containing linker peptide, and use thereof | |
| CN118108860B (zh) | 一种基于FcRn可提高细胞免疫水平的重组疫苗及应用 | |
| IL316351A (en) | Modified western equine encephalitis viruses and uses thereof | |
| EP4001405A1 (en) | Oncolytic virus and application thereof, and drug for treating cancer | |
| JP2002544236A (ja) | 組換えパラポックスウイルスに基づくとりわけ肝の慢性ウイルス感染症ならびに炎症性、変性性および増殖性疾患ならびに癌のための器官、組織および細胞特異的免疫治療薬 | |
| TWI919458B (zh) | 增加藥物產量之機構及改良方法 | |
| KR102766523B1 (ko) | 타겟 조직의 크기 또는 부피 축소용 조성물 또는 이를 포함하는 키트 | |
| US9644015B2 (en) | Codon optimized sequence for an antiviral protein | |
| WO2025180455A1 (en) | A circular rna vaccine against herpes zoster virus and the use thereof |